JP2022535458A5 - - Google Patents

Info

Publication number
JP2022535458A5
JP2022535458A5 JP2021572596A JP2021572596A JP2022535458A5 JP 2022535458 A5 JP2022535458 A5 JP 2022535458A5 JP 2021572596 A JP2021572596 A JP 2021572596A JP 2021572596 A JP2021572596 A JP 2021572596A JP 2022535458 A5 JP2022535458 A5 JP 2022535458A5
Authority
JP
Japan
Prior art keywords
tcr
protein
cells
active
mhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021572596A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535458A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036480 external-priority patent/WO2020247858A1/en
Publication of JP2022535458A publication Critical patent/JP2022535458A/ja
Publication of JP2022535458A5 publication Critical patent/JP2022535458A5/ja
Priority to JP2025076176A priority Critical patent/JP2025118754A/ja
Pending legal-status Critical Current

Links

JP2021572596A 2019-06-07 2020-06-05 Ｂ型肝炎ウイルス特異的なｔ細胞応答 Pending JP2022535458A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076176A JP2025118754A (ja) 2019-06-07 2025-05-01 Ｂ型肝炎ウイルス特異的なｔ細胞応答

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962858764P 2019-06-07 2019-06-07
US62/858,764 2019-06-07
PCT/US2020/036480 WO2020247858A1 (en) 2019-06-07 2020-06-05 Hepatitis b virus-specific t cell responses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076176A Division JP2025118754A (ja) 2019-06-07 2025-05-01 Ｂ型肝炎ウイルス特異的なｔ細胞応答

Publications (2)

Publication Number Publication Date
JP2022535458A JP2022535458A (ja) 2022-08-08
JP2022535458A5 true JP2022535458A5 (https=) 2023-06-01

Family

ID=73653370

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021572596A Pending JP2022535458A (ja) 2019-06-07 2020-06-05 Ｂ型肝炎ウイルス特異的なｔ細胞応答
JP2025076176A Pending JP2025118754A (ja) 2019-06-07 2025-05-01 Ｂ型肝炎ウイルス特異的なｔ細胞応答

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076176A Pending JP2025118754A (ja) 2019-06-07 2025-05-01 Ｂ型肝炎ウイルス特異的なｔ細胞応答

Country Status (5)

Country Link
US (1) US12599658B2 (https=)
EP (1) EP3980061A4 (https=)
JP (2) JP2022535458A (https=)
CN (1) CN113950334B (https=)
WO (1) WO2020247858A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3980061A4 (en) 2019-06-07 2023-07-19 Oregon Health & Science University HEPATITIS B VIRUS SPECIFIC T LYMPHOCYTE RESPONSES
MX2022002270A (es) * 2019-08-29 2022-03-22 Vir Biotechnology Inc Vacunas contra el virus de la hepatitis b.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US9340577B2 (en) * 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
US6417324B1 (en) 2000-04-21 2002-07-09 Tripep Ab Synthetic peptides that bind to the hepatitis B virus core and e antigens
SE9903031D0 (sv) * 1999-08-27 1999-08-27 Eurodiagnostica Ab Peptide mixture and vaccine against a chronic viral infection
US20020069244A1 (en) 1999-11-24 2002-06-06 John Blair Message delivery system billing method and apparatus
US20140014103A1 (en) 2012-07-12 2014-01-16 The Research Foundation Of State University Of New York Methods, Devices and Formulations for Targeted Endobronchial Therapy
WO2008039148A1 (en) 2006-09-28 2008-04-03 Packetfront Sweden Ab Method for automatically providing a customer equipment with the correct service
TWI403247B (zh) 2008-07-18 2013-07-21 Delta Electronics Inc 具把手結構之抽取式電子裝置
JP2013112651A (ja) 2011-11-29 2013-06-10 Niigata Beer Co Ltd トリュフ抽出物を含有したｄｈｅａ産生促進剤及びその用途
FR2993576B1 (fr) 2012-07-20 2018-05-18 Nanoplas Dispositif de traitement d'un objet par plasma
US9603790B2 (en) 2012-11-15 2017-03-28 Basf Corporation Cosmetic compositions comprising marine plants
WO2014135209A1 (en) 2013-03-06 2014-09-12 SiEVA Apparatus for high side transistor bridge driver
US10532099B2 (en) 2016-10-18 2020-01-14 Oregon Health & Science University Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
EP3980061A4 (en) 2019-06-07 2023-07-19 Oregon Health & Science University HEPATITIS B VIRUS SPECIFIC T LYMPHOCYTE RESPONSES

Similar Documents

Publication Publication Date Title
Shinnick The 65-kilodalton antigen of Mycobacterium tuberculosis
JP6816031B2 (ja) 非標準的なｃｄ８＋ｔ細胞応答を生成するのに有用な方法および組成物
JP2019525914A5 (https=)
Cicin-Sain Cytomegalovirus memory inflation and immune protection
PH12021550030A1 (en) Nucleotide sequences encoding peptide antigens of sars-cov-2 virus and use thereof
JP2019527055A5 (https=)
JP2018528237A5 (https=)
CN103160530B (zh) 一种融合基因及其应用
JP2022536122A5 (https=)
US20110150920A1 (en) Allergy Vaccines Containing Hybrid Polypeptides
Sciammas et al. TCRγδ cells and viruses
JP2019506175A5 (https=)
JP7146926B2 (ja) Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン
JP2022535458A5 (https=)
Lu et al. Epitope analysis, expression and protection of SAG5A vaccine against Toxoplasma gondii
CN101475938A (zh) 包虫病抗原基因即egG1Y162抗原基因及其重组蛋白和应用
JP2021507712A5 (https=)
JP2023522154A5 (https=)
CN101451145A (zh) 基于t细胞表位的结核基因疫苗及其制备方法和应用
CN115894708B (zh) 一种人巨细胞病毒抗原表位嵌合肽及其应用
CN102178950B (zh) 一种亚单位疫苗免疫佐剂及应用
JP2010535504A5 (https=)
SE9900812L (sv) Riktad immunoterapi
JP2003527073A5 (https=)
US12599658B2 (en) Hepatitis B virus-specific T cell responses